Determining aetiology in dilated cardiomyopathy – does the ‘cardiomyopathy blood panel’ ameliorate clinical assessment?

Key Points

• Limited utility of the cardiomyopathy blood panel in identifying aetiology in dilated cardiomyopathy cases has been noted.
• Only a small proportion of idiopathic dilated cardiomyopathy cases were linked to specific aetiologies through blood tests.
• Assessment focusing on aetiological relevance reveals a continued challenge in managing dilated cardiomyopathy effectively.
• Future research may highlight the need for alternative diagnostic approaches in idiopathic dilated cardiomyopathy cases.